Back to Vitamins & Minerals
Vitamins & Minerals

Omega-3 Fatty AcidsEvidence & Dosage

EPA, DHA, ALA: daily needs, sources (fish, algae), Omega-3 index as biomarker, and cardiovascular RCT data.

Studies last updated

Evidence at a glance

Total studies
1,000
With abstract
50
Meta / Systematic / RCT
187
Highly cited
50
Publication years
1990–2026

Omega-3 Fatty Acids in the context of Vitamins & Minerals

This topic is part of our "Vitamins & Minerals" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Vitamins & Minerals

Top studies on Omega-3 Fatty Acids

Ranked by influential-citation count and publication year.

  1. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease.

    Arch Intern Med2009Systematic Review200 influential citations

    <h4>Background</h4>Although a wealth of literature links dietary factors and coronary heart disease (CHD), the strength of the evidence supporting valid associations has not been evaluated systematically in a single…

  2. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.

    JAMA Cardiol2018n=77,917Meta-Analysis200 influential citations

    <h4>Importance</h4>Current guidelines advocate the use of marine-derived omega-3 fatty acids supplements for the prevention of coronary heart disease and major vascular events in people with prior coronary heart disease, but large trials…

    Finding: Randomization to omega-3 fatty acid supplementation had no significant association with coronary heart disease death in this meta-analysis.

  3. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

    Cochrane Database Syst Rev2020n=162,796meta169 influential citations

    BACKGROUND: Omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3)), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid (ALA)) may benefit…

    Finding: Increasing ALA intake probably makes little or no difference to all-cause mortality.

  4. Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials.

    Crit Rev Food Sci Nutr2024n=8,489Meta-Analysis167 influential citations

    Literature is inconsistent regarding the effects of omega-3 polyunsaturated fatty acids (omega-3 PUFAs) supplementation on patients with metabolic syndrome (MetS) and related cardiovascular diseases (CVDs). Therefore, the aim of this…

  5. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.

    J Am Heart Assoc2019n=127,477meta138 influential citations

    Background Whether marine omega-3 supplementation is associated with reduction in risk of cardiovascular disease (CVD) remains controversial. Methods and Results This meta-analysis included study-level data from 13 trials. The outcomes of…

    Finding: Marine omega-3 supplementation was associated with a significantly lower risk of myocardial infarction in the analysis excluding REDUCE-IT.

  6. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality.

    Circulation2019n=68,659Meta-Analysis132 influential citations

    Background: Global dietary recommendations for and cardiovascular effects of linoleic acid, the major dietary omega-6 fatty acid, and its major metabolite, arachidonic acid, remain controversial. To address this uncertainty and inform…

    Finding: Higher linoleic acid levels were associated with lower risk of total cardiovascular disease in this pooled analysis.

  7. A systemic review of the roles of n-3 fatty acids in health and disease.

    J Am Diet Assoc2009Systematic Review125 influential citations

    Attention to the role of n-3 long-chain fatty acids in human health and disease has been continuously increased during recent decades. Many clinical and epidemiologic studies have shown positive roles for n-3 fatty acids in infant…

  8. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

    Cochrane Database Syst Rev2018n=112,059meta118 influential citations

    BACKGROUND: Researchers have suggested that omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid…

    Finding: Increasing LCn3 probably makes little or no difference to all-cause mortality.

  9. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.

    Circulation2019n=24Meta-Analysis105 influential citations

    Background: Randomized trials of therapies that primarily lowered triglycerides have not consistently shown reductions in cardiovascular events. Methods: We performed a systematic review and trial-level meta-regression analysis of 3…

    Finding: When REDUCE-IT was removed, the triglyceride association was attenuated and was no longer statistically significant.

  10. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.

    J Clin Psychiatry2011n=916Meta-Analysis102 influential citations

    <h4>Objective</h4>Randomized trials of omega-3 polyunsaturated fatty acid (PUFA) treatment for depression have differed in outcome. Recent meta-analyses ascribe discrepancies to differential effects of eicosapentaenoic acid (EPA) versus…

    Finding: The meta-analysis found that EPA proportion of at least 60% was a significant determinant of superiority of PUFA over placebo.

Frequently asked

What dosage was studied?
• Dietary exposures and dietary patterns • Increased intake of omega-3 fatty acids: long-chain omega-3 (LCn3; EPA/DHA) and alpha-linolenic acid (ALA), via supplements, enriched foods, or dietary advice (LCn3 doses ranged from 0.5 g/day to >5 g/day; 19 RCTs gave at least 3 g LCn3 daily)
Which population does the evidence apply to?
Most studies investigated: unknown; patient.
Are there safety considerations for Omega-3 Fatty Acids?
• Little or no effect on serious adverse events was reported. • LCn3 doses ranged from 0.5 g/day to >5 g/day. • 19 RCTs used at least 3 g LCn3 daily. • Not reported in the abstract

Related articles

Knowledge

Omega-3 Fatty Acids - What Are the Scientific Evidence?

Omega-3 fatty acids have a positive effect on the cardiovascular system. Studies show a reduction in heart attacks and strokes. The recommended daily dose is 250-500 mg EPA+DHA.

Blog

Omega-3 Fatty Acids: Effects, Dosage, and the Evidence at a Glance

Evidence-based overview of Omega-3 fatty acids: what is established, where the data are limited, which doses have been studied, and what matters more in everyday life?

More topics in Vitamins & Minerals

Magnesium

Magnesium types, sleep, cramps, stress, and dosage.

Creatine Monohydrate

Power, muscle building, cognition, and safety of creatine.

Ashwagandha

Stress, sleep, cortisol, and possible side effects.

Melatonin Optimization

Melatonin needs, dosing (0.3-5 mg), extended-release forms, circadian rhythm, and long-term safety considerations.

Caffeine + L-Theanine

Caffeine, L-Theanine, focus, alertness and tolerance.

NAD+ Precursors

NMN, NR, NAD+, aging biology and evidence landscape.

Vitamin Optimization

Vitamin optimization strategies: needs assessment, bioavailability, synergies, and safety upper limits for the most relevant micronutrients.

Melatonin Signaling

Melatonin as a multi-system hormone: antioxidant, immunomodulatory, mitochondrial, and neuroprotective effects beyond sleep.

Animal vs Human Studies

Mouse ≠ human — translatability from resveratrol to rapamycin is shaky.

Bias

Sponsorship, selection bias, confirmation bias, industry funding.

Cardiovascular System

Blood pressure, heart rate, endothelium, cholesterol, cardiovascular risk factors.

Contraindications

When something must NOT be taken: pregnancy, pre-existing conditions.

Coenzyme Q10 (CoQ10 / Ubiquinol)

Mitochondria, statins, energy, and cardiovascular outcomes.

Correlation vs Causation

The classic misinterpretation of popular health studies.

Curcumin

Inflammation, bioavailability (piperine), turmeric extracts, and clinical outcomes.

Digestive System

Stomach acid, enzymes, absorption, the gut-brain axis, the microbiome.

Effect Size

p-value vs. practical relevance, Cohen's d, confidence intervals.

Ferritin & Iron

Ferritin, transferrin saturation, iron deficiency vs. iron overload.

Glutathione

Master antioxidant, liposomal vs. NAC forms and detoxification.

Immune System

Innate vs. adaptive immunity, inflammation, autoimmunity.

Related topics from other worlds

Longevity

Senolytics (Fisetin)

Cellular senescence, Fisetin protocols, and senolytic studies.

Longevity

Visceral Fat

Belly fat around the organs — metabolically very active and pro-inflammatory.

Mental

Breathwork

Box breathing, 4-7-8, Wim Hof, pranayama — autonomic regulation.

Mental

Depth Psychology

Psychodynamic therapy, transference, long-term change.

Mental

Journaling (Mental)

Expressive writing, gratitude — reducing stress, anxiety and depression.

Mental

Panic Attacks

Panic attacks, the neurobiology, breathing and cognitive strategies.